Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

87810 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-09-24

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A systematic literature review (SLR) will be conducted to understand the landscape of evidence on the relative safety and effectiveness/efficacy of dronedarone compared to sotalol in patients with AFib within interventional clinical trials and observational studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI

NCT01182376

Atrial Fibrillation

COMPLETED PHASE3

Dronedarone Rhythm Intervention for Early Atrial Fibrillation

NCT07270848

Atrial Fibrillation (AF)

NOT_YET_RECRUITING PHASE4

Analysis of Endocavitary Electrical Signal and Surface Electrocardiogram to Predict Ablation Outcome in Persistent Atrial Fibrillation

NCT03937089

Atrial Fibrillation

COMPLETED

First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation

NCT05939076

Atrial Fibrillation, Persistent

NOT_YET_RECRUITING PHASE3

The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.

NCT07077811

Cardiovascular Diseases Heart Failure Atrial Fibrillation (AF) +1 more

ENROLLING_BY_INVITATION NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dronedarone

Pharmaceutical form is tablet and route of administration is oral

Intervention Type DRUG

sotalol

Pharmaceutical form is tablet and route of administration is oral

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Multaq® BETAPACE®

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Following eligibility criteria are defined to select relevant studies from the literature

* Adults with Atrial Fibrillation(AFib) (non-permanent, including paroxysmal or persistent, long-standing persistent AFib \[over 12 months\]))
* Participants have received either Dronedarone or Sotalol
* controlled clinical trials or comparative observational studies( prospective/retrospective cohort, case-control studies, population-based studies or registry based studies